Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Progressive Forms of Multiple Sclerosis With Pulsed ACTH (Acthar Gel)

NCT01950234 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT01950234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01950234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Progressive Forms of Multiple Sclerosis With Pulsed ACTH (Acthar Gel)
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Terminated
Start date
April 17, 2014
Completion date
December 31, 2022
Enrollment
59 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

primary progressive multiple sclerosis, progressive relapsing multiple sclerosis, secondary progressive multiple sclerosis